MedKoo Cat#: 597411 | Name: Enkephalinamide-leu

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Enkephalinamide-leu stimulates pituitary adrenocortical activity .

Chemical Structure

Enkephalinamide-leu
Enkephalinamide-leu
CAS#60117-24-0

Theoretical Analysis

MedKoo Cat#: 597411

Name: Enkephalinamide-leu

CAS#: 60117-24-0

Chemical Formula: C28H38N6O6

Exact Mass: 554.2853

Molecular Weight: 554.64

Elemental Analysis: C, 60.63; H, 6.91; N, 15.15; O, 17.31

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.
Bulk Inquiry
Related CAS #
No Data
Synonym
Enkephalinamide-leu; Leu-enkephalinamide; Leucine enkephalinamide;
IUPAC/Chemical Name
(S)-2-((S)-2-(2-(2-((S)-2-amino-3-(4-hydroxyphenyl)propanamido)acetamido)acetamido)-3-phenylpropanamido)-4-methylpentanamide
InChi Key
YZXGODHVAJPXSG-VABKMULXSA-N
InChi Code
InChI=1S/C28H38N6O6/c1-17(2)12-22(26(30)38)34-28(40)23(14-18-6-4-3-5-7-18)33-25(37)16-31-24(36)15-32-27(39)21(29)13-19-8-10-20(35)11-9-19/h3-11,17,21-23,35H,12-16,29H2,1-2H3,(H2,30,38)(H,31,36)(H,32,39)(H,33,37)(H,34,40)/t21-,22-,23-/m0/s1
SMILES Code
CC(C)C[C@@H](C(N)=O)NC([C@H](CC1=CC=CC=C1)NC(CNC(CNC([C@H](CC2=CC=C(O)C=C2)N)=O)=O)=O)=O
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>3 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.03.00
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 554.64 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1: Cros CD, Toth I, Blanchfield JT. Lipophilic derivatives of leu-enkephalinamide: in vitro permeability, stability and in vivo nasal delivery. Bioorg Med Chem. 2011 Feb 15;19(4):1528-34. doi: 10.1016/j.bmc.2010.12.042. Epub 2010 Dec 29. PubMed PMID: 21273080. 2: Turon M, Fogel WA, Bugajski J. Alpha-fluoromethylhistidine decreases the Leu-enkephalinamide- and morphine-induced corticosterone response in rats. Pharmacology. 1991;42(4):188-96. PubMed PMID: 1712972. 3: Thornhill JA, Saunders WS. Blood pressure responses of conscious rats to intravenous administration of enkephalin derivatives (D-ala2 methionine and leucine enkephalinamide, and methionine and leucine enkephalinamide. Peptides. 1985 Nov-Dec;6(6):1253-6. PubMed PMID: 3834418. 4: Liu S, Shibata A, Ueno S, Xu F, Baba Y, Jiang D, Li Y. Investigation of interaction of Leu-enkephalin with lipid membranes. Colloids Surf B Biointerfaces. 2006 Mar 15;48(2):148-58. Epub 2006 Mar 6. PubMed PMID: 16542826. 5: Roubini E, Laufer R, Gilon C, Selinger Z, Roques BP, Chorev M. Pseudopeptide analogues of substance P and leucine enkephalinamide containing the psi (CH2O) modification: synthesis and biological activity. J Med Chem. 1991 Aug;34(8):2430-8. PubMed PMID: 1714957. 6: Mizuma T, Ohta K, Awazu S. Intestinal absorption and analgesic activity of aminopeptidase-resistant cellobiose-coupled leucine enkephalinamide. Biopharm Drug Dispos. 1998 Dec;19(9):605-10. PubMed PMID: 9872343. 7: Sugg EE, Portoghese PS. Investigation of 4-(3-hydroxyphenyl)-4-methylpipecolic acid as a conformationally restricted mimic of the tyrosyl residue of leucine-enkephalinamide. J Med Chem. 1986 Oct;29(10):2028-33. PubMed PMID: 3020252. 8: Gwak HS, Cho YM, Chun IK. Analgesic effects of intra-nasal enkephalins. J Pharm Pharmacol. 2003 Sep;55(9):1207-12. PubMed PMID: 14604463. 9: Hojo K, Ichikawa H, Onishi M, Fukumori Y, Kawasaki K. Peptide synthesis 'in water' by a solution-phase method using water-dispersible nanoparticle Boc-amino acid. J Pept Sci. 2011 Jul;17(7):487-92. doi: 10.1002/psc.1367. Epub 2011 Apr 14. PubMed PMID: 21495120. 10: Bawab W, Aloyz RS, Crine P, Roques BP, DesGroseillers L. Identification and characterization of a neutral endopeptidase activity in Aplysia californica. Biochem J. 1993 Dec 1;296 ( Pt 2):459-65. PubMed PMID: 8257438; PubMed Central PMCID: PMC1137717. 11: Too CK, Murphy PR, Croll RP. Western blotting of formaldehyde-fixed neuropeptides as small as 400 daltons on gelatin-coated nitrocellulose paper. Anal Biochem. 1994 Jun;219(2):341-8. PubMed PMID: 7915887. 12: Stüber W, Knolle J, Breipohl G. Synthesis of peptide amides by Fmoc-solid-phase peptide synthesis and acid labile anchor groups. Int J Pept Protein Res. 1989 Sep;34(3):215-21. PubMed PMID: 2599759. 13: Sivanandaiah KM, Babu VV, Renukeshwar C. Fmoc-amino acid chlorides in solid phase synthesis of opioid peptides. Int J Pept Protein Res. 1992 Mar;39(3):201-6. PubMed PMID: 1399258. 14: Curcuruto O, Hamdan M. Effects of target identity and collision energy on the fragmentation of some mass-selected protonated neuropeptides. Rapid Commun Mass Spectrom. 1993 Nov;7(11):989-93. PubMed PMID: 7904194. 15: Hersh LB, Morihara K. Comparison of the subsite specificity of the mammalian neutral endopeptidase 24.11 (enkephalinase) to the bacterial neutral endopeptidase thermolysin. J Biol Chem. 1986 May 15;261(14):6433-7. PubMed PMID: 3516994. 16: Temussi PA, Tancredi T, Pastore A, Castiglione-Morelli MA. Experimental attempt to simulate receptor site environment. A 500-MHz 1H nuclear magnetic resonance study of enkephalin amides. Biochemistry. 1987 Dec 1;26(24):7856-63. PubMed PMID: 2827761. 17: Dobson G, Murrell J, Despeyroux D, Wind F, Tabet JC. Investigation into factors affecting precision in ion trap mass spectrometry using different scan directions and axial modulation potential amplitudes. J Mass Spectrom. 2004 Nov;39(11):1295-304. PubMed PMID: 15472990. 18: Barr JM, Van Stipdonk MJ. Multi-stage tandem mass spectrometry of metal cationized leucine enkephalin and leucine enkephalin amide. Rapid Commun Mass Spectrom. 2002;16(6):566-78. PubMed PMID: 11870894.